Vaccines and Public Health
Adult immunization rates are falling short of national targets. Learn how global, federal, and state policies affect vaccination uptake. Leverage our findings to guide your strategies. Rely on our expertise commercializing novel and therapeutic vaccines.
Updated Analysis Finds Sustained Drop in Routine Vaccines Through 2020
In 2020, the COVID-19 pandemic resulted in nationwide lockdowns and restrictions with a well-documented impact on utilization of routine healthcare services.
Accurate COVID-19 Testing to Protect the Military and Support Schools
The US continues to face challenges with managing COVID-19 (SARS-CoV-2) while reopening communities. Accurate COVID-19 diagnostic testing is an effective tool in minimizing the risk of transmission.
Avalere Statement on US Support of TRIPS Waiver for COVID Vaccines
On May 5, the Biden administration announced its support for waiving World Trade Organization (WTO) intellectual property regulations with respect to COVID-19 vaccines, in an effort to increase supply and worldwide access to the vaccines.
Jason Hall and Tom Hess Bring Additional Vaccine Expertise to Avalere
They bring more than 35 years of combined healthcare experience and expertise in the immunization development sector.
The Need for a Centralized Immunization Information System
Immunization Information Systems (IIS), or immunization registries, are used across the US to provide consolidated and complete accounts of patient immunization history in a given city, state, or region.
Webinar: Equity for Seniors: Using Data to Guide COVID-19 Pandemic Recovery
Join leading experts from Avalere Health and Tivity Health to learn more about new analyses detailing seniors’ lived experiences with the COVID-19 pandemic, including recent survey data on the vaccine rollout nationwide.
Strengthening Our Public Health Infrastructure: COVID-19 Lessons
Amid the continuing pandemic and calls for healthcare reform, the new administration seeks to confront the myriad public health issues facing our country today.
mAb Utilization for COVID-19 Remains Low, Despite Availability
Since the beginning of the Public Health Emergency (PHE), manufacturers have been developing monoclonal antibodies (mAbs) and other treatment modalities to prevent and treat COVID-19.
Senior Preferences for COVID-19 Vaccination Released with Tivity Health
The COVID-19 pandemic has disproportionately impacted seniors nationwide, with this population at an increased risk of hospitalization or death following a COVID-19 diagnosis.
Considerations in Ensuring Equitable COVID-19 Vaccine Administration
On January 21, the Biden administration released its National Strategy for the COVID-19 Response and Pandemic Preparedness. The plan highlights numerous actions that the administration intends to implement as it assumes responsibility in the fight against COVID-19.
Webinar: COVID-19: Lessons Learned and the Path Forward
Join Avalere’s panel of policy, public health, and regulatory experts to learn about the challenges, opportunities, and key milestones to watch.
How COVID-19 Has Impacted US Adolescent and Adult Vaccine Utilization
Globally and in the US, widespread vaccination has demonstrated medical, economic, and social value to both individuals and public health and has contributed to reductions in morbidity and mortality of certain diseases.
Considerations for Employers in the Era of the COVID-19 Vaccine
On December 14, 2020, an intensive care unit nurse in New York was the first American to receive an injection of the COVID-19 vaccine.
Improving the Public Health Impact of Pediatric Prevention Innovations
As the pipeline of novel vaccines expands, so does the pipeline for other “vaccine-like” products.
CMS Takes Steps to Expand Access to COVID-19 Antibody Treatment
The Centers for Medicare & Medicaid Services (CMS) released coding and payment instructions associated with the first physician-administered outpatient COVID-19 therapeutic. The release specifies that during the public health emergency (PHE), Medicare will cover and pay for these infusions in the same way it does for COVID-19 vaccines.
Payer Experiences with COVID-19
New Avalere research featuring payer views of COVID-19 finds a heightened concern about the clinical effectiveness of related future vaccines and therapeutics, a substantial reduction in preventive services due to the COVID-19 public health emergency, and a significant uptick in telehealth adoption.
Interview: Designing Pull Funding for a COVID-19 Vaccine
Tune into another episode of Avalere’s Journal Club Review podcast series on Avalere Health Essential Voice. In this segment, our health policy experts discuss a recent study in which a simulation was used to determine whether pull funding could overcome issues related to speed, scaling, and pricing for a COVID-19 vaccine.
COVID-19 and Influenza Vaccine Distribution Stakeholder Considerations
The convergence of the seasonal influenza and the current COVID-19 vaccines will merge several distribution considerations for a diverse group of stakeholders.
How Do Biden’s and Trump’s Public Health Platforms Compare?
The November 2020 election is widely anticipated to have important implications for how the US responds to COVID-19.
The COVID-19 Impact on US Routine and Seasonal Vaccine Administrations
Avalere conducted a national survey of more than 200 independent primary care providers concerning the impacts of the COVID-19 pandemic on their ability to support continued vaccination programs for patients. Over 90% of respondents indicated the COVID-19 pandemic has increased operating costs and led to revenue loss. Eighty-two percent indicated that an increase in vaccine administration fees would aid sites in overcoming barriers arising from the COVID-19 pandemic, and 75% expressed interest in implementing new care delivery arrangements to facilitate immunizations during the COVID-19 pandemic.